๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsed Pediatric ALL

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia NCT05366218Phase 1, Phase 211 sites๐Ÿ“ Freiburg im Breisgau๐Ÿ“ Tรผbingen๐Ÿ“ Ulm University Hospital Tuebingen ยท Tests: Tafasitamab Orphan Indications for CD19 Redirected Autologous T Cells NCT04276870Phase 21 site๐Ÿ“ Philadelphia Stephan Grupp MD PhD ยท Tests: Murine CART19 Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis NCT07220252Phase 2, Phase 33 sites๐Ÿ“ Gdansk๐Ÿ“ Poznan๐Ÿ“ Warsaw TG Therapeutics, Inc. ยท Tests: Ublituximab, Placebo, Placebo, Fingolimod A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01) NCT06941272Phase 1, Phase 264 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ New Haven Merck Sharp & Dohme LLC ยท Tests: Patritumab Deruxtecan Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites๐Ÿ“ New Delhi๐Ÿ“ Puducherry University of Geneva, Switzerland CD-19 CAR-T Cell for Pediatric ALL or Lymphoma NCT06866873NA1 site๐Ÿ“ Hong Kong Hong Kong Children's Hospital ยท Tests: CAR-T PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML NCT05105152Phase 11 site๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: SC-DARIC33 ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma NCT04634357Phase 1, Phase 24 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ San Francisco Eureka Therapeutics Inc. ยท Tests: ET140203 T Cells Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ฮถ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) NCT03938987Phase 1, Phase 26 sites๐Ÿ“ Calgary๐Ÿ“ Calgary๐Ÿ“ Calgary University of Alberta ยท Tests: autologous CD19-directed chimeric antigen receptor (CAR) T-cells Determining the Mechanisms of Loss of CAR T Cell Persistence NCT05809284n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ Manchester University College, London A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) NCT06561074Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Decitabine, Venetoclax, Calaspargase pegol-mknl Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management. NCT06464016n/a1 site๐Ÿ“ Lyon Claude Bernard University ยท Tests: Ventricular Assist Device with Berlin Heart EXCOR taVNS for FRNS in Children NCT05588063NA2 sites๐Ÿ“ New Hyde Park๐Ÿ“ Philadelphia Northwell Health ยท Tests: Transcutaneous auricular vagus nerve stimulation, Sham device Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) NCT07360977NA1 site๐Ÿ“ Messina IRCCS Centro Neurolesi Bonino Pulejo ยท Tests: bioactivated GRA for adult patients, bioactivated GRA for pediatric patients Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse NCT06649253NA3 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Rennes Rennes University Hospital ยท Tests: Sampling bone tissue and blood Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma NCT03721068Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin B7-H3.CD28Z.CART in Solid Tumors NCT07358260Phase 11 site๐Ÿ“ Boston Robbie Majzner ยท Tests: B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma NCT04134559Phase 25 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Boston Allison O'Neill, MD ยท Tests: Pembrolizumab Niclosamide in Pediatric Patients With Relapsed and Refractory AML NCT05188170Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: Niclosamide Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR NCT03676504Phase 1, Phase 22 sites๐Ÿ“ Heidelberg๐Ÿ“ Heidelberg University Hospital Heidelberg ยท Tests: CD19.CAR T Cells, Fludarabine, Cyclophosphamide A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) NCT07630974Phase 1, Phase 234 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ St. Petersburg Merck Sharp & Dohme LLC ยท Tests: Ifinatamab Deruxtecan Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors NCT07662018n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Gemcitabine (GEM), Docetaxel, Melphalan, Carboplatin A Multi-Institution Study of TGFฮฒ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue NCT05634369Phase 1, Phase 222 sites๐Ÿ“ South Birmingham๐Ÿ“ Phoenix๐Ÿ“ Little Rock Nationwide Children's Hospital ยท Tests: GEM/DOX + TGFBi expanded NK cells A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) NCT07306832Phase 114 sites๐Ÿ“ Palo Alto๐Ÿ“ Atlanta๐Ÿ“ Valhalla AbbVie ยท Tests: Pivekimab Sunirine A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment NCT04928677Phase 15 sites๐Ÿ“ Los Angeles๐Ÿ“ Atlanta๐Ÿ“ Boston Memorial Sloan Kettering Cancer Center ยท Tests: Codrituzumab Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma NCT07502287Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTNB-NK, Fludarabine, Cyclophosphamide Losartan + Sunitinib in Treatment of Osteosarcoma NCT03900793Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Losartan, Sunitinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy